SG Americas Securities
FULC icon

SG Americas Securities’s Fulcrum Therapeutics FULC Stock Holding History

SG Americas Securities’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40K Sell
10,966
-1,173
-10% -$7.13K ﹤0.01% 3225
2026
Q1 		$93K Buy
12,139
+373
+3% +$3.46K ﹤0.01% 2947
2025
Q4 		$133K Buy
+11,766
New +$120K ﹤0.01% 3105
2025
Q2 		– Sell
-25,375
Closed -$73K – 3177
2025
Q1 		$73K Sell
25,375
-5,067
-17% -$18.6K ﹤0.01% 3144
2024
Q4 		$143K Sell
30,442
-2,577
-8% -$9.51K ﹤0.01% 2449
2024
Q3 		$118K Buy
33,019
+6,926
+27% +$51.4K ﹤0.01% 2934
2024
Q2 		$162K Buy
26,093
+13,887
+114% +$105K ﹤0.01% 2278
2024
Q1 		$115K Buy
+12,206
New +$109K ﹤0.01% 2445
2023
Q2 		– Sell
-24,951
Closed -$71K – 2597
2023
Q1 		$71K Buy
24,951
+8,918
+56% +$79.9K ﹤0.01% 3004
2022
Q4 		$117K Buy
16,033
+4,198
+35% +$27.4K ﹤0.01% 2612
2022
Q3 		$96K Sell
11,835
-1,338
-10% -$9.58K ﹤0.01% 2867
2022
Q2 		$65K Buy
13,173
+8,884
+207% +$86.8K ﹤0.01% 3227
2022
Q1 		$101K Sell
4,289
-7,563
-64% -$107K ﹤0.01% 2768
2021
Q4 		$210K Sell
11,852
-7,376
-38% -$146K ﹤0.01% 2650
2021
Q3 		$542K Buy
+19,228
New +$364K ﹤0.01% 2420
2020
Q3 		– Sell
-6,862
Closed -$126K – 2966
2020
Q2 		$126K Buy
+6,862
New +$108K ﹤0.01% 3212

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SG Americas Securities's FULC Position: Q2 2026 in Review

SG Americas Securities reduced its Fulcrum Therapeutics (FULC) stake by 9.7% in Q2 2026, selling an estimated $7.13K and leaving 10,966 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #3225.

SG Americas Securities first reported a position in FULC in Q2 2020 and has held it in 16 quarters since. The position peaked at $542K in Q3 2021. 154 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • SG Americas Securities held 10,966 shares of Fulcrum Therapeutics worth $40K as of Q2 2026.
  • SG Americas Securities sold 1,173 Fulcrum Therapeutics shares in Q2 2026, an estimated $7.13K.
  • Fulcrum Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3225 holding.
  • SG Americas Securities first reported a position in Fulcrum Therapeutics in Q2 2020 and has held it in 16 quarters since.
  • SG Americas Securities's Fulcrum Therapeutics position peaked at $542K in Q3 2021.
  • 154 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.